Literature DB >> 1437143

Catalytic properties, tissue and intracellular distribution of neurofibromin.

M Golubić1, M Roudebush, S Dobrowolski, A Wolfman, D W Stacey.   

Abstract

The neurofibromatosis type 1 (NF1) gene encodes a protein, neurofibromin, that shows homology with members of the GTPase-activating protein (GAP) family. To study neurofibromin, rabbit polyclonal antisera were raised against two synthetic peptides. These antisera immunoprecipitated a specific protein of about 240 kDa in lysates of adult murine and rat tissues both in the soluble (S100) and to a lesser degree in the particulate (P100) fractions. The neurofibromin immunoprecipitated from the lysates of several murine organs stimulated the intrinsic GTPase activity of p21 c-Ha-ras protein. Based on immunoblotting, immunoprecipitation and GTPase assays, neurofibromin appears to be at least 10-fold more abundant in the brain than in the other murine organs. The GTPase-stimulatory activity of full-length neurofibromin, like the catalytic GAP-related domain, is inhibited by arachidonic acid and the detergent dodecyl maltoside, while phosphatidic acid, containing arachidonic and stearic acid, is non-inhibitory. Immunofluorescence analysis with anti-neurofibromin sera in NIH3T3 cells suggests that at least some of the cellular protein associates with cytoplasmic structures that are distinct from actin or tubulin filaments.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437143

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cell.

Authors:  T Nakamura; T Nemoto; M Arai; Y Yamazaki; T Kasuga; D H Gutmann; F S Collins; T Ishikawa
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

2.  Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons.

Authors:  Melissa N Hinman; Alok Sharma; Guangbin Luo; Hua Lou
Journal:  Mol Cell Biol       Date:  2014-04-07       Impact factor: 4.272

3.  Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.

Authors:  V Aaltonen; P J Boström; K O Söderström; O Hirvonen; J Tuukkanen; M Nurmi; M Laato; J Peltonen
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

4.  Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase.

Authors:  H A Kim; B Ling; N Ratner
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

5.  Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat.

Authors:  F Persichetti; C M Ambrose; P Ge; S M McNeil; J Srinidhi; M A Anderson; B Jenkins; G T Barnes; M P Duyao; L Kanaley
Journal:  Mol Med       Date:  1995-05       Impact factor: 6.354

6.  Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.

Authors:  T A Rizvi; S Akunuru; G de Courten-Myers; R C Switzer; M L Nordlund; N Ratner
Journal:  Brain Res       Date:  1999-01-16       Impact factor: 3.252

7.  A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein.

Authors:  N Ratner; G S Bloom; S T Brady
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

Review 8.  How does the Schwann cell lineage form tumors in NF1?

Authors:  Steven L Carroll; Nancy Ratner
Journal:  Glia       Date:  2008-11-01       Impact factor: 8.073

9.  Reduced expression of neurofibromin in human meningiomas.

Authors:  V Sundaram; J H Lee; J A Harwalkar; D J Stein; M Roudebush; D W Stacey; M Golubic
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.

Authors:  T Rosenbaum; Y L Boissy; K Kombrinck; C I Brannan; N A Jenkins; N G Copeland; N Ratner
Journal:  Development       Date:  1995-11       Impact factor: 6.868

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.